Pamela Esposito - Dec 9, 2022 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Role
Chief Business Officer
Signature
/s/ Jean Franchi, attorney-in-fact
Stock symbol
REPL
Transactions as of
Dec 9, 2022
Transactions value $
-$360,300
Form type
4
Date filed
12/13/2022, 07:01 PM
Previous filing
Jun 16, 2022
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REPL Common Stock Options Exercise $15.2K +15K +6.54% $1.01* 244K Dec 9, 2022 Direct
transaction REPL Common Stock Sale -$375K -15K -6.14% $25.03 229K Dec 9, 2022 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REPL Employee Stock Option (right to buy) Options Exercise $0 -15K -29.3% $0.00 36.2K Dec 9, 2022 Common Stock 15K $1.01 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 13, 2021, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
F2 The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $25 to $25.14. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 Following the sales reported on this Form 4, the reporting person continues to beneficially own 229,402 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 477,227 shares of the Issuer's common stock, 378,400 of which are exercisable as of the date hereof.
F4 The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof.